Monthly Archives: October 2015

Escalating Drug Prices Are Unsustainable

The release of several new, astonishingly expensive, specialty medications has renewed the discussion over prescription drug pricing.  The new hepatitis C drugs, Harvoni ($94,500 for a 12-week course) and Sovaldi ($84,000 for a 12-week course) are emblematic.  Kaiser Health News … Continue reading

Posted in Advocacy, Healthcare Policy, High Value Care | Leave a comment


Last month, ACP released a position paper on telemedicine in primary care settings.  The use of telemedicine is growing rapidly, so the policy recommendations are timely.  In the paper, four types of telemedicine are described: 1) asynchronous, which consists of … Continue reading

Posted in Patient Care | Leave a comment